Last reviewed · How we verify

NCT05302895

Efficiency of an All-in-one Health Monitoring Device in Elderly Residential Setting

Completed Last updated 6 March 2023
What this trial tests

trial testing All-in-one health monitoring device in Technology in 23 participants. Completed in 1 September 2022.

Timeline
12 May 2022
Primary endpoint
19 August 2022
1 September 2022

Quick facts

Lead sponsorThe University of Hong Kong
StatusCompleted
Study typeOBSERVATIONAL
Enrollment23
Start date12 May 2022
Primary completion19 August 2022
Estimated completion1 September 2022
Sites2 locations across Hong Kong

Drugs / interventions tested

Conditions studied

Sponsor

The University of Hong Kong

Who can join

Eligibility, any sex, with Technology. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study explores the benefits from the application of an all-in-one health monitoring device by care staff in old-age home setting: whether the average time consumed for measuring vital signs (including temperature, blood pressure and SpO2) will be shortened after the adoption of the new device. The study also assesses the satisfaction and perceived usability of the stakeholders towards the all-in-one health monitoring device.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Technology

Currently open trials in the same condition.

Other The University of Hong Kong trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05302895.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing